Literature DB >> 1916697

Immunolocalization of urokinase-type plasminogen activator in adenomas and carcinomas of the colorectum.

C F Sier1, C Fellbaum, H W Verspaget, M Schmitt, G Griffioen, H Graeff, H Hôfler, C B Lamers.   

Abstract

Carcinogenesis in the human colon is associated with a marked increase in the tissue content of the urokinase-type plasminogen activator (u-PA). This study was performed to determine the type of cells responsible for the u-PA increase in carcinomas of the colon and in their precursor lesions, the adenomas, by immunohistological evaluation applying monoclonal antibody 3689 directed to the beta-chain of u-PA. Normal intestinal mucosa (n = 17) showed hardly any staining of u-PA, but some lamina propria cells were faintly positive. Carcinomas (n = 17) and adenomas (n = 16) showed a considerable and comparable staining intensity of u-PA in neoplastic columnar epithelial cells, and this staining was found to be diffuse and cytoplasmic. In a majority of the neoplastic tissues the u-PA staining was found to be patchy and not related to known risk markers of malignancy such as dysplasia in the adenomas, or to prognostic determinants such as Dukes' classification or differentiation in the carcinomas. The observation of strong u-PA positive lamina propria cells in adenomas but infrequently observed in normal mucosa and carcinomas was noteworthy. u-PA staining intensity of the tissue sections was found to correlate well with the u-PA antigen level in the tissue extracts determined by ELISA (r = 0.52, P = 0.0001) but poorly with the u-PA activity determined enzymatically (r = 0.28, P = 0.05). In conclusion, the u-PA increase in neoplasia of the human colon can be attributed to an increased diffuse cytoplasmic content of u-PA in neoplastic columnar epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916697     DOI: 10.1111/j.1365-2559.1991.tb00027.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  13 in total

1.  Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.

Authors:  P Gibson; O Rosella; G Rosella; G Young
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

2.  In situ stromal expression of the urokinase/plasmin system correlates with epithelial dysplasia in colorectal adenomas.

Authors:  I Sordat; P Chaubert; P Protiva; L Guillou; L Mazzucchelli; E Saraga; J Benhattar; C Trân-Thang; A L Blum; G Dorta; B Sordat
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

3.  Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization.

Authors:  S R Harvey; S N Sait; Y Xu; J L Bailey; R M Penetrante; G Markus
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

4.  Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.

Authors:  T J de Vries; P H Quax; M Denijn; K N Verrijp; J H Verheijen; H W Verspaget; U H Weidle; D J Ruiter; G N van Muijen
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

5.  Urokinase type plasminogen activator receptor expression in colorectal neoplasms.

Authors:  S Suzuki; Y Hayashi; Y Wang; T Nakamura; Y Morita; K Kawasaki; K Ohta; N Aoyama; S R Kim; H Itoh; Y Kuroda; W F Doe
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

6.  Urokinase and the intestinal mucosa: evidence for a role in epithelial cell turnover.

Authors:  P R Gibson; I Birchall; O Rosella; V Albert; C F Finch; D H Barkla; G P Young
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

7.  Cellular markers that distinguish the phases of hemangioma during infancy and childhood.

Authors:  K Takahashi; J B Mulliken; H P Kozakewich; R A Rogers; J Folkman; R A Ezekowitz
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  Prognostic role of urokinase-type plasminogen activator in human gliomas.

Authors:  D W Hsu; J T Efird; E T Hedley-Whyte
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

Review 9.  Activities, localizations, and roles of serine proteases and their inhibitors in human brain tumor progression.

Authors:  M Yamamoto; R Sawaya; S Mohanam; V H Rao; J M Bruner; G L Nicolson; K Ohshima; J S Rao
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

10.  Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.

Authors:  C F Sier; H J Vloedgraven; G Griffioen; S Ganesh; F M Nagengast; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.